3D Medical, an ASX-listed medical company that prints customised 3D models of patients’ bones and organs for doctors and surgeons, has acquired United States medical technology business Mach7 in a deal worth $60 million
3D Medical had previously been the exclusive Australian reseller of Mach7’s image management platform.
The company plans to rename after the merger as Mach7 Technologies and will be headquartered in Melbourne. But Mach7’s team will remain predominantly in the United States, with the board being a combination of the two entities.
3D Medical chairman Nigel Finch said the business relied on a seamless supply of medical image data, which it had previously had access to through partnerships with companies such as Canada’s Intelerad, but this would be easier to achieve through the merger with Mach7.Read more